HAOHAI BIOTEC (06826) intends to use temporarily idle funds raised for cash management.
Haohai Biological Technology (06826) issued an announcement to improve the efficiency of the use of funds raised, and to reasonably utilize some temporarily idle funds...
HAOHAI BIOTEC (06826) announced that in order to improve the efficiency of the use of raised funds, it will reasonably utilize some temporarily idle raised funds to increase the company's revenue, ensuring that it does not affect the construction and use of raised fund projects, and that the raised funds are safe and the purpose of the raised funds remains unchanged. The company plans to use up to 300 million yuan (including the principal) of temporarily idle raised funds for cash management, with a validity period of 12 months from the date of approval by the board of directors. Within the above-mentioned limit and period, the funds can be used in a revolving manner.
Related Articles

US Stock Market Move | Rare earth concept stocks have varying ups and downs. MP Materials (MP.US) rose over 5.7%.

US Stock Market Move | Century Aluminum Company (CENX.US) surged more than 17% and its Q3 revenue exceeded expectations.

US Stock Market Move | Genpact Limited (G.US) surged more than 14% as Q3 revenue exceeded expectations, raising 2025 sales guidance.
US Stock Market Move | Rare earth concept stocks have varying ups and downs. MP Materials (MP.US) rose over 5.7%.

US Stock Market Move | Century Aluminum Company (CENX.US) surged more than 17% and its Q3 revenue exceeded expectations.

US Stock Market Move | Genpact Limited (G.US) surged more than 14% as Q3 revenue exceeded expectations, raising 2025 sales guidance.

RECOMMEND

Short Positions on Xiaomi (01810.HK) Surge 53% in a Week as Memory Price Spike Weighs on Sentiment
07/11/2025

Privatization Wave in Hong Kong Stocks: Exiting Liquidity Traps to Enable Strategic Transformation
07/11/2025

Over 30 Foreign Firms Attend Roundtable as Ministry of Commerce Signals Multiple Policy Shifts
07/11/2025


